Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

51 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Comparison of the anti-inflammatory effect of aripiprazole and risperidone in 75 drug-naïve first episode psychosis individuals: A 3 months randomized study.
Juncal-Ruiz M, Riesco-Dávila L, Ortiz-García de la Foz V, Martínez-Garcia O, Ramírez-Bonilla M, Ocejo-Viñals JG, Leza JC, López-Hoyos M, Crespo-Facorro B. Juncal-Ruiz M, et al. Among authors: martinez garcia o. Schizophr Res. 2018 Dec;202:226-233. doi: 10.1016/j.schres.2018.06.039. Epub 2018 Jun 23. Schizophr Res. 2018. PMID: 29941296 Clinical Trial.
Weight gain induced by haloperidol, risperidone and olanzapine after 1 year: findings of a randomized clinical trial in a drug-naïve population.
Perez-Iglesias R, Crespo-Facorro B, Martinez-Garcia O, Ramirez-Bonilla ML, Alvarez-Jimenez M, Pelayo-Teran JM, Garcia-Unzueta MT, Amado JA, Vazquez-Barquero JL. Perez-Iglesias R, et al. Schizophr Res. 2008 Feb;99(1-3):13-22. doi: 10.1016/j.schres.2007.10.022. Epub 2007 Dec 3. Schizophr Res. 2008. PMID: 18053689 Clinical Trial.
Relapse prevention and remission attainment in first-episode non-affective psychosis. A randomized, controlled 1-year follow-up comparison of haloperidol, risperidone and olanzapine.
Crespo-Facorro B, Pérez-Iglesias R, Mata I, Caseiro O, Martínez-Garcia O, Pardo G, Ramirez-Bonilla M, Pelayo-Terán JM, Vázquez-Barquero JL. Crespo-Facorro B, et al. J Psychiatr Res. 2011 Jun;45(6):763-9. doi: 10.1016/j.jpsychires.2010.11.002. Epub 2010 Nov 23. J Psychiatr Res. 2011. PMID: 21106207 Clinical Trial.
Effectiveness of haloperidol, risperidone and olanzapine in the treatment of first-episode non-affective psychosis: results of a randomized, flexible-dose, open-label 1-year follow-up comparison.
Crespo-Facorro B, Pérez-Iglesias R, Mata I, Ramirez-Bonilla M, Martínez-Garcia O, Pardo-Garcia G, Caseiro O, Pelayo-Terán JM, Vázquez-Barquero JL. Crespo-Facorro B, et al. J Psychopharmacol. 2011 Jun;25(6):744-54. doi: 10.1177/0269881110388332. Epub 2011 Feb 3. J Psychopharmacol. 2011. PMID: 21292922 Clinical Trial.
Aripiprazole, ziprasidone, and quetiapine in the treatment of first-episode nonaffective psychosis: results of a 6-week, randomized, flexible-dose, open-label comparison.
Crespo-Facorro B, Pérez-Iglesias R, Mata I, Ortiz-Garcia de la Foz V, Martínez-Garcia O, Valdizan EM, Vazquez-Barquero JL. Crespo-Facorro B, et al. J Clin Psychopharmacol. 2013 Apr;33(2):215-20. doi: 10.1097/JCP.0b013e3182825c1e. J Clin Psychopharmacol. 2013. PMID: 23422371 Clinical Trial.
Comparison of metabolic effects of aripiprazole, quetiapine and ziprasidone after 12 weeks of treatment in first treated episode of psychosis.
Pérez-Iglesias R, Ortiz-Garcia de la Foz V, Martínez García O, Amado JA, Garcia-Unzueta MT, Ayesa-Arriola R, Suarez-Pinilla P, Tabares-Seisdedos R, Crespo-Facorro B. Pérez-Iglesias R, et al. Schizophr Res. 2014 Oct;159(1):90-4. doi: 10.1016/j.schres.2014.07.045. Epub 2014 Aug 20. Schizophr Res. 2014. PMID: 25151200 Clinical Trial.
51 results